<?xml version='1.0' encoding='utf-8'?>
<document id="29442035"><sentence text="Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein."><entity charOffset="58-68" id="DDI-PubMed.29442035.s1.e0" text="carvedilol" /><entity charOffset="73-84" id="DDI-PubMed.29442035.s1.e1" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.29442035.s1.e0" e2="DDI-PubMed.29442035.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29442035.s1.e0" e2="DDI-PubMed.29442035.s1.e1" /></sentence><sentence text="The most widely prescribed oral antiplatelet agent, clopidogrel, shows high interindividual variability resulting in an increased risk of cardiovascular events in the patients with reduced platelet inhibition"><entity charOffset="52-63" id="DDI-PubMed.29442035.s2.e0" text="clopidogrel" /></sentence><sentence text=" The purpose of this study was to investigate the role of the P-glycoprotein (P-gp) efflux pump in limiting the intestinal permeability of clopidogrel and the effect of a β-blocker, namely, carvedilol, on its intestinal transport"><entity charOffset="139-150" id="DDI-PubMed.29442035.s3.e0" text="clopidogrel" /><entity charOffset="190-200" id="DDI-PubMed.29442035.s3.e1" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.29442035.s3.e0" e2="DDI-PubMed.29442035.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29442035.s3.e0" e2="DDI-PubMed.29442035.s3.e1" /></sentence><sentence text=" Effective permeabilities (Peff) of clopidogrel and carvedilol were investigated in the proximal jejunum and distal ileum of rats using an in situ intestinal perfusion model"><entity charOffset="36-47" id="DDI-PubMed.29442035.s4.e0" text="clopidogrel" /><entity charOffset="52-62" id="DDI-PubMed.29442035.s4.e1" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.29442035.s4.e0" e2="DDI-PubMed.29442035.s4.e0" /><pair ddi="false" e1="DDI-PubMed.29442035.s4.e0" e2="DDI-PubMed.29442035.s4.e1" /></sentence><sentence text=" Peff values of clopidogrel and carvedilol were found to be concentration dependent with decreased Peff values at the low perfusate concentrations"><entity charOffset="16-27" id="DDI-PubMed.29442035.s5.e0" text="clopidogrel" /><entity charOffset="32-42" id="DDI-PubMed.29442035.s5.e1" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.29442035.s5.e0" e2="DDI-PubMed.29442035.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29442035.s5.e0" e2="DDI-PubMed.29442035.s5.e1" /></sentence><sentence text=" Coperfusion with the P-gp inhibitors verapamil (100 μM) and carvedilol (10 μM) significantly increased the Peff of clopidogrel in the jejunum (8"><entity charOffset="38-47" id="DDI-PubMed.29442035.s6.e0" text="verapamil" /><entity charOffset="61-71" id="DDI-PubMed.29442035.s6.e1" text="carvedilol" /><entity charOffset="116-127" id="DDI-PubMed.29442035.s6.e2" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.29442035.s6.e0" e2="DDI-PubMed.29442035.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29442035.s6.e0" e2="DDI-PubMed.29442035.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29442035.s6.e0" e2="DDI-PubMed.29442035.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29442035.s6.e1" e2="DDI-PubMed.29442035.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29442035.s6.e1" e2="DDI-PubMed.29442035.s6.e2" /></sentence><sentence text="31±0" /><sentence text="20 x 10-5 and 6" /><sentence text="98±0" /><sentence text="75 x 10-5 vs" /><sentence text=" 3" /><sentence text="60±0" /><sentence text="51 x 10-5, respectively) and ileum (9" /><sentence text="08±2" /><sentence text="19 x 10-5 and 8" /><sentence text="35±1" /><sentence text="58 x 10-5 vs" /><sentence text=" 3" /><sentence text="85±0" /><sentence text="15 x 10-5, respectively)" /><sentence text=" However, at the highest concentration tested (30 μM), clopidogrel exhibited 3 and 1"><entity charOffset="55-66" id="DDI-PubMed.29442035.s21.e0" text="clopidogrel" /></sentence><sentence text="4 times higher Peff than those of metoprolol, an FDA high permeability reference standard, in the jejunum and ileum, respectively"><entity charOffset="34-44" id="DDI-PubMed.29442035.s22.e0" text="metoprolol" /></sentence><sentence text=" Overall, this study indicates that the efflux function appears not to have a significant impact on the in vivo intestinal absorption of clopidogrel due to the saturation of P-gp, suggesting no clinically relevant interaction between carvedilol and clopidogrel mediated through P-gp at intestinal level"><entity charOffset="137-148" id="DDI-PubMed.29442035.s23.e0" text="clopidogrel" /><entity charOffset="234-244" id="DDI-PubMed.29442035.s23.e1" text="carvedilol" /><entity charOffset="249-260" id="DDI-PubMed.29442035.s23.e2" text="clopidogrel" /><pair ddi="false" e1="DDI-PubMed.29442035.s23.e0" e2="DDI-PubMed.29442035.s23.e0" /><pair ddi="false" e1="DDI-PubMed.29442035.s23.e0" e2="DDI-PubMed.29442035.s23.e1" /><pair ddi="false" e1="DDI-PubMed.29442035.s23.e0" e2="DDI-PubMed.29442035.s23.e2" /><pair ddi="false" e1="DDI-PubMed.29442035.s23.e1" e2="DDI-PubMed.29442035.s23.e1" /><pair ddi="false" e1="DDI-PubMed.29442035.s23.e1" e2="DDI-PubMed.29442035.s23.e2" /></sentence><sentence text="" /></document>